Cargando…
Experience Using Paxlovid for Patients With Coronavirus Disease 2019 in a Resource-Limited Emergency Department
Autores principales: | Nene, Rahul V., Navarro, Michael R., Tomaszewski, Christian A., Lafree, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American College of Emergency Physicians.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490110/ https://www.ncbi.nlm.nih.gov/pubmed/36153054 http://dx.doi.org/10.1016/j.annemergmed.2022.05.029 |
Ejemplares similares
-
Use of sotrovimab in vaccinated versus unvaccinated COVID‐19 patients in a resource‐limited emergency department during the omicron surge
por: Nene, Rahul V., et al.
Publicado: (2023) -
Outcomes for in-hospital cardiac arrest for COVID-19 patients at a rural hospital in Southern California
por: Nene, Rahul V., et al.
Publicado: (2021) -
Effective strategies to prevent in-hospital infection in the emergency department during the novel coronavirus disease 2019 pandemic
por: Kung, Chia-Te, et al.
Publicado: (2021) -
Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection
por: Sun, Fangfang, et al.
Publicado: (2022) -
On the choice of Molnupiravir and Paxlovid as the only antivirals permitted for COVID-19 infection in Australia
por: Boretti, Alberto
Publicado: (2023)